Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
0.82
+ 0.02 (+2.38%)
Day High: 0.82
Day Low:  0.75
Volume:    16,933
3:59 PM ET on Sep 26, 2016

Delayed at least 20 minutes.

Events & Presentations

Upcoming events are not available at this time. Sign up for email alerts.